Regeneron Pharmaceuticals Inc., current ratio, long-term trends, calculation

	Current ratio	=	Current assets¹	÷	Current liabilities¹
Dec 31, 2019	3.67	=	7,689,100	÷	2,096,600
Dec 31, 2018	4.47	=	6,447,600	÷	1,442,800
Dec 31, 2017	3.82	=	4,335,030	÷	1,135,483
Dec 31, 2016	2.56	=	3,180,188	÷	1,241,495
Dec 31, 2015	3.59	=	2,915,095	÷	811,162
Dec 31, 2014	3.31	=	2,167,461	÷	654,660
Dec 31, 2013	6.01	=	1,796,934	÷	298,835
Dec 31, 2012	7.37	=	1,206,012	÷	163,550
Dec 31, 2011	4.40	=	652,875	÷	148,271
Dec 31, 2010	3.28	=	357,622	÷	109,056
Dec 31, 2009	4.55	=	425,508	÷	93,575
Dec 31, 2008	6.23	=	521,442	÷	83,672
Dec 31, 2007	2.81	=	797,829	÷	283,664
Dec 31, 2006	10.44	=	469,984	÷	45,014
Dec 31, 2005	8.46	=	341,392	÷	40,357

¹ US$ in thousands

Regeneron Pharmaceuticals Inc., current ratio, long-term trends, comparison to competitors

	Regeneron Pharmaceuticals Inc.	Abbott Laboratories	AbbVie Inc.	Allergan PLC	Amgen Inc.	Biogen Inc.	Bristol-Myers Squibb Co.	Eli Lilly & Co.	Gilead Sciences Inc.	Johnson & Johnson	Merck & Co. Inc.	Pfizer Inc.	Vertex Pharmaceuticals Inc.	Zoetis Inc.
Dec 31, 2019	3.67	1.44	3.18	1.01	1.44	1.72	1.60	1.16	3.10	1.26	1.24	0.88	3.61	2.63
Dec 31, 2018	4.47	1.62	0.98	1.13	2.79	2.32	1.61	1.73	3.38	1.47	1.17	1.57	3.43	3.60
Dec 31, 2017	3.82	2.26	1.28	1.16	5.49	2.34	1.55	1.32	2.74	1.41	1.33	1.35	3.28	3.85
Dec 31, 2016	2.56	4.02	1.65	2.27	4.11	2.55	1.55	1.37	2.22	2.47	1.78	1.25	2.31	3.03
Dec 31, 2015	3.59	1.54	1.50	1.03	4.44	2.60	1.30	1.53	2.50	2.17	1.55	1.49	2.78	2.15
Dec 31, 2014	3.31	1.45	1.41	1.37	4.95	2.11	1.73	1.09	3.07	2.36	1.77	2.67	4.20	3.19
Dec 31, 2013	6.01	2.02	2.59	1.35	3.44	1.81	1.52	1.47	1.15	2.20	2.00	2.41	3.99	2.37
Dec 31, 2012	7.37	2.36	2.27	1.43	3.81	1.96	1.15	1.55	1.44	1.90	1.90	2.15	3.67	2.55
Dec 31, 2011	4.40	1.54	—	1.40	4.80	3.26	1.97	1.60	5.53	2.38	2.04	2.06	3.39	—
Dec 31, 2010	3.28	1.29	—	2.19	3.52	2.42	1.97	2.09	2.32	2.05	1.86	2.11	2.23	—
Dec 31, 2009	4.55	1.79	—	1.68	4.89	3.47	2.21	1.90	2.57	1.82	1.80	1.66	4.59	—
Dec 31, 2008	6.23	1.47	—	3.03	3.12	2.66	2.20	0.95	3.52	1.65	1.35	1.59	4.01	—
Dec 31, 2007	2.81	1.54	—	2.64	2.11	1.08	1.20	2.33	4.11	1.51	1.23	2.15	2.49	—
Dec 31, 2006	10.44	0.94	—	1.83	1.67	2.94	1.59	1.91	3.18	1.20	1.20	2.20	3.07	—
Dec 31, 2005	8.46	1.54	—	5.54	2.57	2.78	1.78	1.89	6.79	2.48	1.58	1.47	3.84	—

Regeneron Pharmaceuticals Inc., current ratio, long-term trends, comparison to sector (pharmaceuticals & biotechnology)

	Regeneron Pharmaceuticals Inc.	Pharmaceuticals & Biotechnology
Dec 31, 2019	3.67	1.53
Dec 31, 2018	4.47	1.72
Dec 31, 2017	3.82	1.78
Dec 31, 2016	2.56	2.11
Dec 31, 2015	3.59	1.89
Dec 31, 2014	3.31	2.16
Dec 31, 2013	6.01	2.11
Dec 31, 2012	7.37	2.07
Dec 31, 2011	4.40	2.23
Dec 31, 2010	3.28	2.02
Dec 31, 2009	4.55	1.93
Dec 31, 2008	6.23	1.64
Dec 31, 2007	2.81	1.72
Dec 31, 2006	10.44	1.56
Dec 31, 2005	8.46	1.82

Regeneron Pharmaceuticals Inc., current ratio, long-term trends, comparison to industry (health care)

	Regeneron Pharmaceuticals Inc.	Health Care
Dec 31, 2019	3.67	1.40
Dec 31, 2018	4.47	1.51
Dec 31, 2017	3.82	1.60
Dec 31, 2016	2.56	1.80
Dec 31, 2015	3.59	1.70
Dec 31, 2014	3.31	1.95
Dec 31, 2013	6.01	1.99
Dec 31, 2012	7.37	1.88
Dec 31, 2011	4.40	2.01
Dec 31, 2010	3.28	1.85
Dec 31, 2009	4.55	1.79
Dec 31, 2008	6.23	1.56
Dec 31, 2007	2.81	1.65
Dec 31, 2006	10.44	1.51
Dec 31, 2005	8.46	1.66

Regeneron Pharmaceuticals Inc. (NASDAQ:REGN)

Current Ratio
since 2005